Merit Financial Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,449
Closed -$368K 216
2020
Q3
$368K Sell
1,449
-466
-24% -$118K 0.03% 167
2020
Q2
$322K Buy
+1,915
New +$322K 0.03% 161